This submission belongs to the 2025 PAGANZ symposium “Pharmacometric approaches in malaria research” Background: Primaquine is a first-line treatment for radical cure of plasmodium vivax malaria. However, questions still remain on what the optimal dosing is, particularly in young children. The present work pooled individual patient data from published studies, which were analysed with a […]
